Subfertility Clinical Trial
Official title:
Fertility and the Microbiome: an Observational Study and Randomized Placebo Controlled Double-blind Pilot Trial
With this study, the investigators want to investigate the microbiome and human papilloma virus (HPV) status of couples with subfertility. The investigators want to gain information about association of female and male microbiome and its impact on fertility. HPV prevalence is high, and its impact on fertility has not been studied intensively. The investigators want to find out whether there is an association between HPV status and subfertility, vaginal and seminal microbiome and HPV status and the prevalence among our subfertile couples. As part of this study, the investigators will perform a randomized placebo controlled double blind pilot study to investigate the association between altered sperm quality (impaired motility and elevated DNA fragmentation index), the seminal microbiome and whether intake of probiotics alters these parameters.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | December 31, 2024 |
Est. primary completion date | April 11, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Couples (Males and females) with subfertility, primary or secondary infertility, or recurrent pregnancy loss. Exclusion Criteria: - unable to consent - diseases or conditions that might impact investigation - intake of probiotics, antibiotics within last 3 months - intake of nutritional supplements - chemo therapy or radiation therapy - excess alcohol intake - smoking |
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Graz | Graz | Styria |
Lead Sponsor | Collaborator |
---|---|
Medical University of Graz |
Austria,
Baud D, Pattaroni C, Vulliemoz N, Castella V, Marsland BJ, Stojanov M. Sperm Microbiota and Its Impact on Semen Parameters. Front Microbiol. 2019 Feb 12;10:234. doi: 10.3389/fmicb.2019.00234. eCollection 2019. — View Citation
Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019 Jul;221(1):9-18.e8. doi: 10.1016/j.ajog.2018.12.011. Epub 2018 Dec 12. — View Citation
Depuydt CE, Donders G, Verstraete L, Vanden Broeck D, Beert J, Salembier G, Bosmans E, DhontT N, Van Der Auwera I, Vandenborne K, Ombelet W. Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks. Facts Views Vis Obgyn. 2018 Dec;10(4):201-205. — View Citation
Depuydt CE, Donders GGG, Verstraete L, Vanden Broeck D, Beert JFA, Salembier G, Bosmans E, Ombelet W. Infectious human papillomavirus virions in semen reduce clinical pregnancy rates in women undergoing intrauterine insemination. Fertil Steril. 2019 Jun;111(6):1135-1144. doi: 10.1016/j.fertnstert.2019.02.002. Epub 2019 Apr 17. — View Citation
Jersoviene V, Gudleviciene Z, Rimiene J, Butkauskas D. Human Papillomavirus and Infertility. Medicina (Kaunas). 2019 Jul 15;55(7):377. doi: 10.3390/medicina55070377. — View Citation
Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morre SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Hum Reprod. 2019 Jun 4;34(6):1042-1054. doi: 10.1093/humrep/dez065. Erratum In: Hum Reprod. 2019 Oct 2;34(10):2091-2092. — View Citation
Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morre SA, de Jonge JD, Poort L, Cuypers WSS, Budding AE, Laven JSE; ReceptIVFity study group. The ReceptIVFity cohort study protocol to validate the urogenital microbiome as predictor for IVF or IVF/ICSI outcome. Reprod Health. 2018 Dec 7;15(1):202. doi: 10.1186/s12978-018-0653-x. — View Citation
Moreno I, Simon C. Relevance of assessing the uterine microbiota in infertility. Fertil Steril. 2018 Aug;110(3):337-343. doi: 10.1016/j.fertnstert.2018.04.041. — View Citation
Simon C. Introduction: Do microbes in the female reproductive function matter? Fertil Steril. 2018 Aug;110(3):325-326. doi: 10.1016/j.fertnstert.2018.06.041. Epub 2018 Jul 20. — View Citation
Xiong YQ, Chen YX, Cheng MJ, He WQ, Chen Q. The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis. Asian J Androl. 2018 Sep-Oct;20(5):493-497. doi: 10.4103/aja.aja_77_17. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Seminal microbiome | 16S-RNA sequencing; shotgun metagenomic sequencing | 3 months | |
Primary | Vaginal microbiome | 16S-RNA sequencing; shotgun metagenomic sequencing | 1 month | |
Primary | Uterine microbiome | 16S-RNA sequencing; shotgun metagenomic sequencing | 1 month | |
Primary | DNA-Fragmentation index | Rate of sperm with elevated DNA Fragmentation index | 3 months | |
Secondary | Hormone status of males and females - LH (Luteinizing hormone) | LH status | 3 months | |
Secondary | Hormone status of males and females - FSH (follicle stimulating hormone) | FSH status | 3 months | |
Secondary | Hormone status of males and females - Testosterone status | Testosterone status | 3 months | |
Secondary | Hormone status of males and females - free Testosterone | free Testosterone status | 3 months | |
Secondary | Hormone status of males and females - Androstenedione | Androstenedione status | 3 months | |
Secondary | Hormone status of males and females - AMH (Anti-Müllerian hormone) | AMH status | 3 months | |
Secondary | Hormone status of males and females - DHEAS (dehydroepiandrosterone sulphate) | DHEAS status | 3 months | |
Secondary | Hormone status of males and females - 25(OH)Vitamin D | 25(OH)Vitamin D status | 3 months | |
Secondary | Hormone status of males and females - TSH (thyroid-stimulating hormone) | TSH status | 3 months | |
Secondary | Hormone status of males and females - fT3 (free Triiodothyronine) | fT3 Status | 3 months | |
Secondary | Hormone status of males and females - freeThyroxine (fT4) | fT4 status | 3 months | |
Secondary | HPV Status | HPV PCR analysis | 3 months | |
Secondary | stool microbiome | 16S-RNA sequencing; shotgun metagenomic sequencing | 3 months | |
Secondary | oral microbiome | 16S-RNA sequencing; shotgun metagenomic sequencing | 3 months | |
Secondary | Cortisol in Saliva | cortisol analysis in saliva of females and males | 3 months | |
Secondary | Amylase in Saliva | amylase analysis in saliva of females and males | 3 months | |
Secondary | Metabolic parameters - Omega 3 | Omega 3 | 3 months | |
Secondary | Metabolic parameters - Omega 6 | Omega 6 | 3 months | |
Secondary | Metabolic parameters - low density lipoprotein | low density lipoprotein | 3 months | |
Secondary | Metabolic parameters - high density lipoprotein | high density lipoprotein | 3 months | |
Secondary | Metabolic parameters - triglycerides | triglycerides | 3 months | |
Secondary | Metabolic parameters - LipoproteinA | LipoproteinA | 3 months | |
Secondary | Time to pregnancy | Time until clinical pregnancy is achieved | 24 months | |
Secondary | pregnancy rate | rate of clinical pregnancies | 24 months | |
Secondary | live birth rate | follow up of pregnancies and their outcome | 24 months | |
Secondary | Presence of sexual transmittable diseases | HBV, HCV, HIV, Syphilis, Chlamydia, Gardnerella, Trichomonas | 3 months | |
Secondary | Sperm count | Motility, concentration, morphology | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
Completed |
NCT03105453 -
The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
|
||
Terminated |
NCT02180256 -
Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial
|
N/A | |
Terminated |
NCT02197832 -
A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles
|
N/A | |
Completed |
NCT00971152 -
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
|
Phase 3 | |
Completed |
NCT01569945 -
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
|
N/A | |
Recruiting |
NCT04064840 -
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
|
Phase 3 | |
Recruiting |
NCT02561793 -
DHEA Versus Placebo in Women With Poor Ovarian Response
|
Phase 3 | |
Terminated |
NCT02570386 -
Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer
|
N/A | |
Completed |
NCT02197208 -
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
|
N/A | |
Completed |
NCT01961336 -
Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF
|
Phase 3 | |
Completed |
NCT02487940 -
Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure
|
Phase 4 | |
Completed |
NCT01385618 -
Gene-polymorphisms Relating to Human Subfertility
|
N/A | |
Completed |
NCT00985062 -
Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization
|
N/A | |
Recruiting |
NCT04538560 -
Preimplantation Genetic Testing for Aneuploidy of Polar Bodies
|
N/A | |
Completed |
NCT02748278 -
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
|
||
Completed |
NCT02044445 -
Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?
|
N/A | |
Completed |
NCT02863614 -
Analgesia for Endometrial Scratching
|
N/A | |
Completed |
NCT02151006 -
Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
|
Phase 3 | |
Completed |
NCT02154958 -
Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility
|
N/A |